Citation Tools

Download PDFPDF
Is There a High-Risk Subgroup of Stage I Epithelial Ovarian Cancer that Is Most Likely to Benefit From 6 Versus 3 Cycles of Adjuvant Chemotherapy?

Download to a citation manager

Cite this article as:
Bakkum-Gamez JN, Richardson DL, Seamon LG, et al
Is There a High-Risk Subgroup of Stage I Epithelial Ovarian Cancer that Is Most Likely to Benefit From 6 Versus 3 Cycles of Adjuvant Chemotherapy?